Integra LifeSciences Appoints Sravan Emany as VP, Treasurer and Investor Relations

2/26/18

Sravan Emany

PLAINSBORO, N.J., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the appointment of Sravan Emany as vice president, treasurer and investor relations. Mr. Emany will be a member of the Integra executive leadership team.

“Sravan has a proven track record of maximizing shareholder value through his extensive involvement in numerous mergers, acquisitions, and corporate financing transactions in the healthcare industry,” said Peter Arduini, president and chief executive officer, Integra LifeSciences. “His healthcare experience, financial acumen and market perspective will be invaluable to Integra as we continue to implement our growth strategies, manage our capital structure efficiently, and meet the company’s liquidity needs.”

Most recently, Mr. Emany was a managing director in the Mergers & Acquisitions group at Bank of America Merrill Lynch. While at Bank of America Merrill Lynch, he led numerous mergers and acquisitions in the healthcare sector, including the recent Integra acquisitions of Codman Neurosurgery and Derma Sciences. Prior to this role, he assumed positions of increasing responsibility in mergers and acquisitions and investment banking at other firms, including Goldman Sachs and Morgan Stanley.

Mr. Emany holds a B.A. in international relations and an M.A. in international relations and international economics from The Johns Hopkins University.

About Integra

Integra LifeSciences Holdings Corporation, a world leader in medical technology, is dedicated to limiting uncertainty for clinicians, so they can concentrate on providing the best patient care. Integra offers innovative solutions, including leading plastic and regenerative technologies, in specialty surgical solutions, orthopedics and tissue technologies. For more information, please visit www.integralife.com.

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.